Physician profile
Tan Chen
NPI 1528603370
$30,253.46
in general payments reported to CMS, 2019-2025
11 companies · $1,983 in 2025
The $1,983 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $914 · 2021: $740 · 2022: $3,139 · 2023: $13K · 2024: $11K · 2025: $1,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $6,973 · Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,600.00 |
| Travel and Lodging | $6,972.70 |
| Food and Beverage | $1,888.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,517.09 | 2021-2025 | Catalyft Pl Expandable Interbody System, Pivox Oblique Lateral Spinal System, Unid_pass |
| Cerapedics INC. | $8,598.99 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $6,955.94 | 2020-2025 | Altera, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Si-Bone, INC. | $979.44 | 2022-2025 | |
| Arthrex, INC. | $462.45 | 2025 | |
| Novus Surgical Consultants | $276.47 | 2025 | |
| Davol INC. | $144.21 | 2023 | Phasix Mesh |
| Stryker Corporation | $118.97 | 2020 | |
| Vb Spine LLC | $93.63 | 2025 | Everest Spinal System |
| Supreme Orthopedic Systems, LLC | $93.14 | 2025 | |
| Medtronic USA, INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tan Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.